Silva, G.F.; da Silva, J.S.; de Alencar, A.K.N.; de Moraes Carvalho da Silva, M.; Montagnoli, T.L.; de Souza Rocha, B.; de Freitas, R.H.C.N.; Sudo, R.T.; Fraga, C.A.M.; Zapata-Sudo, G.
Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats. Pharmaceuticals 2022, 15, 900.
https://doi.org/10.3390/ph15070900
AMA Style
Silva GF, da Silva JS, de Alencar AKN, de Moraes Carvalho da Silva M, Montagnoli TL, de Souza Rocha B, de Freitas RHCN, Sudo RT, Fraga CAM, Zapata-Sudo G.
Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats. Pharmaceuticals. 2022; 15(7):900.
https://doi.org/10.3390/ph15070900
Chicago/Turabian Style
Silva, Grazielle Fernandes, Jaqueline Soares da Silva, Allan Kardec Nogueira de Alencar, Marina de Moraes Carvalho da Silva, Tadeu Lima Montagnoli, Bruna de Souza Rocha, Rosana Helena Coimbra Nogueira de Freitas, Roberto Takashi Sudo, Carlos Alberto Manssour Fraga, and Gisele Zapata-Sudo.
2022. "Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats" Pharmaceuticals 15, no. 7: 900.
https://doi.org/10.3390/ph15070900
APA Style
Silva, G. F., da Silva, J. S., de Alencar, A. K. N., de Moraes Carvalho da Silva, M., Montagnoli, T. L., de Souza Rocha, B., de Freitas, R. H. C. N., Sudo, R. T., Fraga, C. A. M., & Zapata-Sudo, G.
(2022). Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats. Pharmaceuticals, 15(7), 900.
https://doi.org/10.3390/ph15070900
